2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Epigenetics Market?

The escalation of cancer and other diseases is a notable catalyst for the expansion of the epigenetics market. As the occurrence rate of diseases soars, so does the necessity for epigenetics. For instance, the National Cancer Institute (NCI), a government agency in the US, reported nearly 20 million new cancer cases in 2022, culminating in around 9.7 million deaths due to the disease. In May 2024, it was forecasted that by 2040, the yearly onset of new cancer cases will surge to 29.9 million, with deaths from cancer reaching 15.3 million. Additionally, the Centers for Disease Control and Prevention (CDC) state that approximately 659,000 individuals in the United States succumb to heart disease annually. The rising occurrence of cancer and other diseases necessitates testing and understanding the changes that have occurred in the genes, predictably augmenting the utilization and demand of epigenetics. Therefore, the escalating occurrence rate of cancer and other diseases propels the growth of the epigenetics market in forthcoming years.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

How Will the Growth Rate of theEpigenetics Market Impact Industry Trends by 2034?

The size of the epigenetics market has seen significant expansion in the past few years. The market is projected to rise from a value of $10.65 billion in 2024 to $12.83 billion in 2025, achieving a Compound Annual Growth Rate (CAGR) of 20.4%. Factors such as increased funding for research, a growing prevalence of chronic illness, advances in personalized medicine, cancer research, and an aging population contribute to the growth observed in the historical period.

The market for epigenetics is predicted to witness substantial expansion in the coming years, with its value reaching $29.08 billion in 2029 at a compound annual growth rate (CAGR) of 22.7%. The growth anticipated during the forecast period is driven by factors such as development of epigenetic drugs, the role of epigenetics in environmental health and precision agriculture, regulatory backing, as well as increased patient awareness and advocacy. Key trends to watch during this period include epitranscriptomics, single-cell epigenomics, epigenetic editing, use of epigenetic biomarkers, research on aging and longevity, and the interaction between microbiomes and epigenomes.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7070

What Are the Most Significant Market Trends Transforming theEpigenetics Market?

The focal point of major corporations in the epigenetics market is the development of cutting-edge solutions, including DNA sequencing techniques, in order to amplify precision medicine and augment understanding and treatment outcomes for illnesses. DNA sequencing methods, which are used to identify the sequence of nucleotides in a DNA molecule, allow for thorough genetic analysis. Such information forms the backbone of identifying genetic variations associated with diseases and advancing precision medicine. For example, in March 2023, a biotechnology company based in the US, Illumina Inc., introduced Illumina Complete Long Read Technology. This technology facilitates both long-read and short-read sequencing in a single device, thereby amplifying its versatility in genomic research. With its minimized DNA input requirements and an efficient workflow, it uncomplicates the process of library preparation, making it user-friendly for difficult samples. The technology achieves a high degree of precision in variant calling, thereby supplying trustworthy data critical for an all-inclusive genomic analysis.

What Are the Top Market Players Propelling the Growth of the Epigenetics Industry?

Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Which Primary Segments of the Epigenetics Market Are Driving Growth and Industry Transformations?

The epigenetics market covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Epigenetics Market?# Market?

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Gobal Epigenetics Maret 2025, By The Business Research Company:

Tumor Embolization Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

Cancer Tumor Profiling Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: